Annovis Bio Inc (NYSE: ANVS) established initial surge of 5.71% at $4.07, as the Stock market unbolted on Wednesday, before settling in for the price of $3.85 at the close. Taking a more long-term approach, ANVS posted a 52-week range of $1.11-$5.57.
The Healthcare sector firm’s twelve-monthly sales growth has been -73.95% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -73.95%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 43.52%. This publicly-traded company’s shares outstanding now amounts to $26.50 million, simultaneously with a float of $22.41 million. The organization now has a market capitalization sitting at $107.87 million. At the time of writing, stock’s 50-day Moving Average stood at $3.42, while the 200-day Moving Average is $2.50.
Annovis Bio Inc (ANVS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Annovis Bio Inc industry. Annovis Bio Inc’s current insider ownership accounts for 15.45%, in contrast to 11.41% institutional ownership. According to the most recent insider trade that took place on Dec 08 ’25, this organization’s Director bought 45,000 shares at the rate of 4.31, making the entire transaction reach 193,794 in total value, affecting insider ownership by 2,574,739. Preceding that transaction, on Nov 24 ’25, Company’s Director bought 39,200 for 4.08, making the whole transaction’s value amount to 159,886. This particular insider is now the holder of 2,519,739 in total.
Annovis Bio Inc (ANVS) Earnings and Revenue Records
Annovis Bio Inc’s EPS increase for this current 12-month fiscal period is 43.52% and is forecasted to reach -1.30 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 18.51% through the next 5 years, which can be compared against the -73.95% growth it accomplished over the previous five years trading on the market.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
Let’s observe the current performance indicators for Annovis Bio Inc (ANVS). It’s Quick Ratio in the last reported quarter now stands at 4.60.
In the same vein, ANVS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.48, a figure that is expected to reach -0.31 in the next quarter, and analysts are predicting that it will be -1.30 at the market close of one year from today.
Technical Analysis of Annovis Bio Inc (ANVS)
Now, what If we examine the latest scores posted by [Annovis Bio Inc, ANVS]. During the last 5-days, its volume was lower the volume of 0.52 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 83.53% While, its Average True Range was 62.29.
Raw Stochastic average of Annovis Bio Inc (ANVS) in the period of the previous 100 days is set at 63.61%, which indicates a major fall in contrast to 94.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.27 that was higher than 0.25 volatility it exhibited in the past 100-days period.
